Meta Plans To Pledge $65 Million In Support Of AI-Friendly State Politicians: Report
Meta Platforms Inc. (NASDAQ: META) reportedly plans to invest $65 million in 2026 to back state politicians who are supportive of the artificial intelligence (AI) industry.
The initiative will kick off this week in Texas and Illinois and marks the company’s largest election-related expenditure to date, The New York Times reported earlier this week.
However, in light of potential regulatory threats to the AI industry, Meta is escalating its political involvement. The company’s goal is to counteract any legislation in states that could potentially obstruct AI development.
As part of this strategy, Meta has launched two new super political action committees (PACs), Forge the Future Project and Making Our Tomorrow, which will support Republicans and Democrats, respectively. These PACs join two others previously established by Meta, bringing the total initial budget to $65 million.
Forge the Future Project, led by Brian Baker, a GOP strategist, is gearing up to support pro-Republican legislators in Texas, home to Meta's three AI data centers. On the other hand, Making Our Tomorrow in Illinois concentrates on electing Democrats who advocate for their policy priorities.
Meta has generally taken a cautious approach to politics, contributing modestly via its corporate PACs and making donations to presidential inaugurations. Last year, CEO Mark Zuckerberg donated $1 million to President Donald Trump‘s inauguration.
Meta did not immediately respond to Benzinga‘s request for comment.
Surge in Political Spending Amid AI Push
The report of Meta’s investment comes amid a surge in political fundraising ahead of the 2026 midterm elections. Billionaire Elon Musk also resumed his financial support for Republicans, making significant donations, despite announcing in 2025 that he planned to pull back from political spending.
Earlier this month, Trump’s political fundraising reached $375 million, a significant amount that could potentially reshape the upcoming midterms and future elections.
Meanwhile, the regulatory environment for technology is poised for a marked shift. In December, Trump signed an executive order establishing a national AI framework, aiming to override state regulations he says hinder U.S. leadership. He emphasized AI's importance for national security and economic dominance, warning that state-level laws threaten America's position in the global AI race.
Image via Shutterstock
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
